Valuation: Getinge AB

Capitalization 53.33B 5.8B 5B 4.51B 4.33B 7.89B 533B 8.26B 21.37B 255B 21.75B 21.29B 914B P/E ratio 2025
26.4x
P/E ratio 2026 * 18.2x
Enterprise value 62.21B 6.76B 5.83B 5.26B 5.05B 9.21B 621B 9.64B 24.92B 298B 25.38B 24.84B 1,066B EV / Sales 2025
1.7x
EV / Sales 2026 * 1.72x
Free-Float
79.05%
Yield 2025 *
2.51%
Yield 2026 * 2.51%
1 day-0.38%
1 week-3.50%
Current month-3.50%
1 month-3.93%
3 months-7.29%
6 months-6.67%
Current year-10.51%
1 week 193.2
Extreme 193.2
201.3
1 month 193.2
Extreme 193.2
206.9
Current year 193.2
Extreme 193.2
227.8
1 year 177.25
Extreme 177.25
231.6
3 years 164.35
Extreme 164.35
275.2
5 years 164.35
Extreme 164.35
431.6
10 years 74.74
Extreme 74.74
431.6
Manager TitleAgeSince
Chief Executive Officer 54 2017-04-30
Director of Finance/CFO - 2024-03-30
Compliance Officer 47 2020-09-30
Director TitleAgeSince
Chairman 65 2019-04-22
Chairman 75 -
Director/Board Member 70 2006-12-31
Change 5d. change 1-year change 3-years change Capi.($)
-0.38%-3.50%-9.48%-11.12% 5.8B
-0.58%-1.67%+23.24%+33.00% 13.29B
-0.02%+0.04%+0.52%-0.92% 9.16B
+2.62%-2.14%+33.36%+39.75% 5.54B
+1.74%-4.65%+0.03%+13.85% 5.34B
-2.94%0.00% - - 5.19B
+1.54%-6.23%-9.26%+37.50% 4.72B
+2.82%-2.83%+5.88%-54.63% 1.7B
-8.36%-4.61%-35.38%-82.59% 1.48B
+4.17%+2.68%+38.37%-1.27% 1.45B
Average +0.06%-1.62%+5.25%-2.93% 5.37B
Weighted average by Cap. +0.08%-1.64%+8.52%+12.78%

Financials

2025 2026 *
Net sales 35.38B 3.84B 3.31B 2.99B 2.87B 5.24B 353B 5.48B 14.17B 169B 14.43B 14.12B 606B 35.53B 3.86B 3.33B 3.01B 2.88B 5.26B 355B 5.5B 14.24B 170B 14.49B 14.19B 609B
Net income 2.51B 273M 235M 213M 204M 372M 25.1B 389M 1.01B 12.04B 1.03B 1B 43.05B 2.88B 313M 269M 243M 233M 426M 28.72B 445M 1.15B 13.77B 1.17B 1.15B 49.26B
Net Debt 8.88B 965M 832M 751M 721M 1.31B 88.72B 1.38B 3.56B 42.54B 3.62B 3.55B 152B 7.62B 828M 714M 644M 618M 1.13B 76.09B 1.18B 3.05B 36.49B 3.11B 3.04B 130B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,670
Date Price Change Volume
26-03-06 195.80 kr -0.38% 347,544
26-03-05 196.55 kr -1.43% 374,900
26-03-04 199.40 kr +2.18% 660,237
26-03-03 195.15 kr -1.51% 867,503
26-03-02 198.15 kr -2.34% 508,777
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
195.80SEK
Average target price
228.11SEK
Spread / Average Target
+16.50%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. GETI B Stock